Mark Schoenberg
Chief Medical Officer at UroGen Pharma Ltd. (URGN)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $4.5M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 9SEC | URGNUroGen Pharma Ltd. | Sell | 87159,882 held (−1%) | $42.92 | $37K | -14.2% |
| Aug 24SEC | URGNUroGen Pharma Ltd. | Sell | 60,67759,086 held (−51%) | $47.05 | $2.9M | -21.7% |
| Jul 10SEC | URGNUroGen Pharma Ltd. | Sell Plan | 10,000119,763 held (−8%) | $40.00 | $400K | -7.9% |
| Jun 24SEC | URGNUroGen Pharma Ltd. | Sell Plan | 10,000129,763 held (−7%) | $35.01 | $350K | +5.2% |
| Jun 9SEC | URGNUroGen Pharma Ltd. | Sell | 5,222139,763 held (−4%) | $27.30 | $143K | +34.9% |
| May 11SEC | URGNUroGen Pharma Ltd. | Sell Plan | 10,000134,985 held (−7%) | $30.00 | $300K | +22.8% |
| Feb 4SEC | URGNUroGen Pharma Ltd. | Sell | 1,844150,514 held (−1%) | $19.69 | $36K | +87.0% |
| Feb 4SEC | URGNUroGen Pharma Ltd. | Sell | 1,843148,671 held (−1%) | $19.69 | $36K | +87.0% |
| Feb 4SEC | URGNUroGen Pharma Ltd. | Sell | 3,686144,985 held (−2%) | $19.69 | $73K | +87.0% |
| Nov 20SEC | URGNUroGen Pharma Ltd. | Sell Plan | 10,000139,025 held (−7%) | $25.00 | $250K | +47.3% |
- Sell
Chief Medical Officer Mark Schoenberg sold $2.9M of URGN at $47.05 — cuts the stake by 51%.
- Sell
Chief Medical Officer Mark Schoenberg sold $400K of URGN at $40.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Mark Schoenberg sold $350K of URGN at $35.01 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Mark Schoenberg sold $300K of URGN at $30.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Mark Schoenberg sold $250K of URGN at $25.00 — pre-scheduled 10b5-1 plan sale.